Stocks and Investing Stocks and Investing
Thu, November 30, 2023
Wed, November 29, 2023
Tue, November 28, 2023
Mon, November 27, 2023

Raghuram Selvaraju Maintained (TRDA) at Strong Buy with Decreased Target to $20 on, Nov 27th, 2023


Published on 2024-10-28 07:44:10 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Maintained "Entrada Therapeutics, Inc." (TRDA) at Strong Buy with Decreased Target from $25 to $20 on, Nov 27th, 2023.

Raghuram, nor any peers, have made any analyst calls on TRDA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30